Raza Syed Abbas, Mahmood Nasir
Department of Internal Medicine, Shaukat Khanum Hospital and Research Center, Lahore, Pakistan.
Department of Internal Medicine, Junnah Hospital, Lahore, Pakistan.
Indian J Endocrinol Metab. 2013 Dec;17(Suppl 3):S636-42. doi: 10.4103/2230-8210.123555.
Diagnoses of subclinicaal hypothyroidism (SCH) is biochemically made, when serum thyroid stimulating hormone (TSH) levels is elevated while free thyroid hormone levels are within normal reference range. SCH is diagnosed after excluding all other causes of elevated TSH levels. Symptoms of SCH may vary from being asymptomatic to having mild nonspecific symptoms. The risk of progression to overt hypothyroidism is related to number of factors including initial serum TSH concentration, presence of auto antibodies, family history and presence goiter. Various screening recommendations for thyroid function assessment are in practice. There are still controversies surrounding SCH and associated risk of various cardiovascular diseases (CVDs), pregnancy outcomes, neuropsychiatric issues, metabolic syndrome, and dyslipidemia. Consensus will require more large randomized clinical studies involving various age groups and medical condition, especially in developing countries. All these efforts will definitely improve our understanding of disease and ultimately patient outcomes.
亚临床甲状腺功能减退症(SCH)的诊断基于生化指标,即血清促甲状腺激素(TSH)水平升高而游离甲状腺激素水平在正常参考范围内。在排除所有其他导致TSH水平升高的原因后,方可诊断为SCH。SCH的症状可能从无症状到有轻微的非特异性症状不等。进展为显性甲状腺功能减退症的风险与多种因素有关,包括初始血清TSH浓度、自身抗体的存在、家族史和甲状腺肿的存在。目前有各种关于甲状腺功能评估的筛查建议在实际应用中。围绕SCH以及其与各种心血管疾病(CVD)、妊娠结局、神经精神问题、代谢综合征和血脂异常的相关风险仍存在争议。达成共识需要更多涉及不同年龄组和医疗状况的大型随机临床研究,尤其是在发展中国家。所有这些努力肯定会增进我们对该疾病的理解,并最终改善患者的预后。